Related Experiment Video
Updated: Jul 13, 2026
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
[Effects of the novel tumor/testis antigen, Biot2, on proliferation of NIH3T3 cell]
Chun-ting Wang1, Peng Zhang, Feng Peng
1State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Aim:
To study the biological effects of the novel tumor/testis antigen Biot2 on proliferation of NIH3T3 cell and to identify the preliminary biological functions of it.
Methods:
The Biot2 gene was amplified by RT-PCR and cloned into the eukaryotic expression vector pcDNA3.1(+) to construct the pcDNA3.1-Biot2 plasmid. The recombinant plasmid pcDNA3.1-Biot2 was transfected into NIH3T3 cell by lipofectamine 2000, and then the positive clones were screened by G418. The expression of pcDNA3.1(+) and Biot2 mRNA in positive clones were detected by RT-PCR, Realtime RT-PCR and Western blot, respectively. The cell growth curves were measured by MTT assay to study the changes of proliferation of the NIH3T3 cells stably transfected by pcDNA3.1-Biot2 plasmid and the controls.
Results:
The eukaryotic expression vecter pcDNA3.1-Biot2 was successfully constructed. The expression of pcDNA3.1(+) vecter was found by RT-PCR. Biot2 mRNA transcription and protein were detected by Realtime RT-PCR and Western blot respectively. The growth rate of NIH3T3 cells stably transfected by the recombinant plasmid was faster than that of the controls.
Conclusion:
The stable pcDNA3.1-Biot2 transfected NIH3T3 cell line is successfully established, and the proliferation of the cells stadly transfected is promoted, which will provide experimental basis for further study on biotherapy using Biot2 target antigen.
Insights
The novel tumor antigen Biot2 promotes NIH3T3 cell proliferation. This study establishes a Biot2-transfected cell line, providing a basis for biotherapy research.
Area of Science:
- Molecular Biology
- Cell Biology
- Biotechnology
Context:
- Novel tumor/testis antigen Biot2's biological roles require investigation.
- Understanding Biot2's function is crucial for potential biotherapy applications.
- NIH3T3 cells provide a model system for studying cellular proliferation.
Purpose:
- To investigate the biological effects of Biot2 on NIH3T3 cell proliferation.
- To identify preliminary biological functions of the Biot2 antigen.
Summary:
- The Biot2 gene was cloned into a eukaryotic expression vector (pcDNA3.1-Biot2) and transfected into NIH3T3 cells.
- Successful stable transfection was confirmed via RT-PCR, Real-time RT-PCR, and Western blot, detecting Biot2 mRNA and protein expression.
- MTT assays demonstrated that NIH3T3 cells expressing Biot2 exhibited significantly increased proliferation rates compared to control cells.
Impact:
- Successfully established a stable NIH3T3 cell line expressing Biot2.
- Demonstrated Biot2's role in promoting cellular proliferation.
- Provides a foundation for further research into Biot2-based biotherapies.
